HISTORY OF OUTCOME MEASURES FOR MYASTHENIA GRAVIS

被引：40

作者：

Burns, Ted M. ^{[1
]}

机构：

[1] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA

来源：

MUSCLE & NERVE | 2010年 / 42卷 / 01期

关键词：

myasthenia gravis; outcome measures; MG Composite; MG-QOL15; rating scales; QUALITY-OF-LIFE; SELF-ADMINISTERED QUESTIONNAIRE; ALTERNATE-DAY PREDNISONE; LONG-TERM CORRELATION; MYCOPHENOLATE-MOFETIL; DOUBLE-BLIND; INTRAVENOUS IMMUNOGLOBULIN; ACETYLCHOLINE-RECEPTORS; RANDOMIZED-TRIAL; CLINICAL-TRIAL;

D O I：

10.1002/mus.21713

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

This review illustrates how measurements of clinical status in patients with myasthenia gravis have evolved from clinical descriptions and estimates of mortality rates to more sophisticated evaluative instruments, including numerical rating scales that measure strength, endurance, quality of life, and activities of daily living. The rationale and use of weighting and the importance of patient-reported outcomes are also discussed. The measurement of the steroid-sparing effect of an immunosuppressant is also reviewed. Muscle Nerve 42: 5-13, 2010

引用

页码：5 / 13

页数：9

共 50 条

[31] Outcome and antibody profile in ocular myasthenia gravis
Galassi, G.
Mazzoli, M.
Ariatti, A.
Kaleci, S.
Valzania, F.
Nichelli, P.
EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 95 - 95
[32] THE OUTCOME OF THYMECTOMY IN NONTHYMOMATOUS MYASTHENIA-GRAVIS
HUANG, MH
KING, KL
HSU, WH
HUANG, BS
HSU, HK
WANG, LS
CHIEN, KY
SURGERY GYNECOLOGY & OBSTETRICS, 1988, 166 (05): : 436 - 440
[33] The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis
Katz, Natalie K.
Barohn, Richard J.
NEUROPHARMACOLOGY, 2021, 182
[34] Single-fiber electromyography compared to outcome measures in controlled study of mycophenolate mofetil in myasthenia gravis
Massey, J. M.
Sanders, D. B.
Saperstein, D. S.
Barohn, R. J.
Meriggioli, M. N.
Nations, S. P.
Muscle, S.
MUSCLE & NERVE, 2007, 36 (04) : 594 - 594
[35] PREGNANCY IN MYASTHENIA GRAVIS AND NEONATAL MYASTHENIA GRAVIS
SCHLEZINGER, NS
AMERICAN JOURNAL OF MEDICINE, 1955, 19 (05): : 718 - 720
[36] OUTCOME OF PLASMAPHERESIS IN MYASTHENIA GRAVIS: DELAYED THERAPY IS NOT FAVORABLE
Mandawat, Aditya
Mandawat, Anant
Kaminski, Henry J.
Shaker, Zaid A.
Alawi, Aws A.
Alshekhlee, Amer
MUSCLE & NERVE, 2011, 43 (04) : 578 - 584
[37] Treatment outcome in juvenile-onset myasthenia gravis
Jastrzebska, Aleksandra
Jastrzebski, Milosz
Ryniewicz, Barbara
Kostera-Pruszczyk, Anna
MUSCLE & NERVE, 2019, 59 (05) : 549 - 554
[38] THE COURSE OF MYASTHENIA-GRAVIS AND THERAPIES AFFECTING OUTCOME
GROB, D
ARSURA, EL
BRUNNER, NG
NAMBA, T
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 505 : 472 - 499
[39] Comparison of Conservative Treatment and Thymectomy on Myasthenia Gravis Outcome
Taioli, Emanuela
Paschal, Philip Kent
Liu, Bian
Kaufman, Andrew J.
Flores, Raja M.
ANNALS OF THORACIC SURGERY, 2016, 102 (06): : 1805 - 1813
[40] Factors influencing the outcome of transsternal thymectomy for myasthenia gravis
Huang, CS
Hsu, HS
Huang, BS
Lee, HC
Kao, KP
Hsu, WH
Huang, MH
ACTA NEUROLOGICA SCANDINAVICA, 2005, 112 (02): : 108 - 114

← 1 2 3 4 5 →